Bailard’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-29,508
Closed -$187K – 756
2026
Q2
$187K Buy
+29,508
New +$145K ﹤0.01% 741
2019
Q4
– Sell
-15,300
Closed -$91K – 543
2019
Q3
$91K Buy
+15,300
New +$97.3K 0.01% 519

Other funds holding ASPN

Bailard's ASPN Position: Q3 2026 in Review

Bailard sold out of Aspen Aerogels (ASPN) in Q3 2026, closing a stake of 29,508 shares — an estimated $187K sold.

Bailard first reported a position in ASPN in Q3 2019 and held it in 2 quarters. The position peaked at $187K in Q2 2026. 12 funds tracked by Wall St. Rank hold ASPN as of Q3 2026.

  • Bailard reported no remaining Aspen Aerogels position as of Q3 2026 after selling out during the quarter.
  • Bailard sold 29,508 Aspen Aerogels shares in Q3 2026, an estimated $187K.
  • Bailard first reported a position in Aspen Aerogels in Q3 2019 and held it in 2 quarters.
  • Bailard's Aspen Aerogels position peaked at $187K in Q2 2026.
  • 12 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2026.

Based on Bailard's 13F filing for Q3 2026, filed 13 Oct 2026.